| |

Prediction: Buying Rivian Stock Today Could Set You Up for Life

There may never be another Tesla (NASDAQ: TSLA). Shares of the company have increased in value by 27,000% since 2010. A small initial investment could have become hundreds of thousands of dollars over that time. Tesla’s high-profile leader, Elon Musk, has pushed the company into many lucrative verticals, everything from electric vehicles and solar power…

| |

Is Rocket Lab a High-Risk, High-Reward Opportunity?

Few stocks have captured the imagination like Rocket Lab (NASDAQ: RKLB), a leader among a crop of young companies racing to turn the promise of the space economy into a reality. Rocket Lab went public in late 2020 as part of a special purpose acquisition company (SPAC) deal, and its journey since then has been…

| |

Nvidia Just Became the World’s Most Valuable Company. Here’s What May Happen Next.

Nvidia (NASDAQ: NVDA) might be the company everyone’s talking about thanks to its dominance in the high-growth area of artificial intelligence (AI), but it remained behind one other tech player, Microsoft, in terms of market value. Until this week. On June 3, Nvidia roared past the software giant to become the world’s most valuable company…

| | |

Planet Labs (PL) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, June 4, 2025 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer, Chairperson, and Co-Founder — Will Marshall President, Chief Financial Officer, and Chief Operating Officer — Ashley Johnson Need a quote from one of our analysts? Email pr@fool.com RISKS President Ashley Johnson said civil government revenue decreased…

| | | | |

Prediction: Tesla Stock Won’t Recover in 2025 (And Insiders Seem to Agree)

Between Tesla (NASDAQ: TSLA) failing to meet the deadlines that Elon Musk sets and Musk’s decision to split his time at Tesla with various other endeavors, many investors are losing confidence and questioning whether the stock can recover from its plunge in 2025. But the actions of Tesla insiders are providing a clear indication. Two…